At Large: Are agents ever ‘legal’ under the FCPA?
Richard L. Cassin
August 6, 2020
My serious purpose in asking if agents are legal under the FCPA is about compliance with the accounting standards.… Continue Reading
Editors
Harry Cassin
Publisher and Editor
Andy Spalding
Senior Editor
Jessica Tillipman
Senior Editor
Bill Steinman
Senior Editor
Richard L. Cassin
Editor at Large
Elizabeth K. Spahn
Editor Emeritus
Cody Worthington
Contributing Editor
Julie DiMauro
Contributing Editor
Thomas Fox
Contributing Editor
Marc Alain Bohn
Contributing Editor
Bill Waite
Contributing Editor
Russell A. Stamets
Contributing Editor
Richard Bistrong
Contributing Editor
Eric Carlson
Contributing Editor
Posts Tagged: Alexion
Alexion Pharmaceuticals pays SEC $21.4 million to resolve FCPA offenses
Richard L. Cassin
July 2, 2020
Connecticut-based Alexion Pharmaceuticals, Inc. agreed to pay $21.4 million to resolve SEC charges that the company violated the FCPA by bribing foreign officials in Turkey and Russia, and failing to maintain accurate books and records at subsidiaries in Brazil and Colombia.… Continue Reading
FCPA enforcement report for Q2 2020
Harry Cassin
July 1, 2020
During the second calendar quarter — amid the Covid-19 lockdown — there were two corporate FCPA enforcement actions. For comparison, during the second calendar quarter last year, there were three corporate FCPA enforcement actions, and during Q2 2018, there were five corporate FCPA enforcement actions.… Continue Reading
DOJ joins Alexion FCPA investigation
Richard L. Cassin
November 9, 2015
Alexion Pharmaceuticals Inc. said in a securities filing that the Justice Department is now investigating the company’s grant-making activities and its compliance with the Foreign Corrupt Practices Act.
Connecticut-based Alexion received a subpoena from the SEC in May.… Continue Reading